BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 28378028)

  • 1. Up-regulation of autophagy is a mechanism of resistance to chemotherapy and can be inhibited by pantoprazole to increase drug sensitivity.
    Tan Q; Joshua AM; Wang M; Bristow RG; Wouters BG; Allen CJ; Tannock IF
    Cancer Chemother Pharmacol; 2017 May; 79(5):959-969. PubMed ID: 28378028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of pantoprazole to enhance activity of docetaxel against human tumour xenografts by inhibiting autophagy.
    Tan Q; Joshua AM; Saggar JK; Yu M; Wang M; Kanga N; Zhang JY; Chen X; Wouters BG; Tannock IF
    Br J Cancer; 2015 Mar; 112(5):832-40. PubMed ID: 25647012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A possible involvement of Nrf2-mediated heme oxygenase-1 up-regulation in protective effect of the proton pump inhibitor pantoprazole against indomethacin-induced gastric damage in rats.
    Lee HJ; Han YM; Kim EH; Kim YJ; Hahm KB
    BMC Gastroenterol; 2012 Oct; 12():143. PubMed ID: 23066659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton pump inhibitor pantoprazole abrogates adriamycin-resistant gastric cancer cell invasiveness via suppression of Akt/GSK-β/β-catenin signaling and epithelial-mesenchymal transition.
    Zhang B; Yang Y; Shi X; Liao W; Chen M; Cheng AS; Yan H; Fang C; Zhang S; Xu G; Shen S; Huang S; Chen G; Lv Y; Ling T; Zhang X; Wang L; Zhuge Y; Zou X
    Cancer Lett; 2015 Jan; 356(2 Pt B):704-12. PubMed ID: 25449432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal effects of pantoprazole on multidrug resistance in human gastric adenocarcinoma cells by down-regulating the V-ATPases/mTOR/HIF-1α/P-gp and MRP1 signaling pathway in vitro and in vivo.
    Chen M; Huang SL; Zhang XQ; Zhang B; Zhu H; Yang VW; Zou XP
    J Cell Biochem; 2012 Jul; 113(7):2474-87. PubMed ID: 22396185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of the proton pump inhibitor pantoprazole to modify the distribution and activity of doxorubicin: a potential strategy to improve the therapy of solid tumors.
    Patel KJ; Lee C; Tan Q; Tannock IF
    Clin Cancer Res; 2013 Dec; 19(24):6766-76. PubMed ID: 24141627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton pump inhibitor pantoprazole inhibits the proliferation, self‑renewal and chemoresistance of gastric cancer stem cells via the EMT/β‑catenin pathways.
    Feng S; Zheng Z; Feng L; Yang L; Chen Z; Lin Y; Gao Y; Chen Y
    Oncol Rep; 2016 Dec; 36(6):3207-3214. PubMed ID: 27748935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Autophagy as a Survival Mechanism for Hypoxic Cells in Tumors.
    Tan Q; Wang M; Yu M; Zhang J; Bristow RG; Hill RP; Tannock IF
    Neoplasia; 2016 Jun; 18(6):347-55. PubMed ID: 27292024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pantoprazole, an FDA-approved proton-pump inhibitor, suppresses colorectal cancer growth by targeting T-cell-originated protein kinase.
    Zeng X; Liu L; Zheng M; Sun H; Xiao J; Lu T; Huang G; Chen P; Zhang J; Zhu F; Li H; Duan Q
    Oncotarget; 2016 Apr; 7(16):22460-73. PubMed ID: 26967058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Esomeprazole overcomes paclitaxel-resistance and enhances anticancer effects of paclitaxel by inducing autophagy in A549/Taxol cells.
    Bai Z; Ding N; Ge J; Wang Y; Wang L; Wu N; Wei Q; Xu S; Liu X; Zhou G
    Cell Biol Int; 2021 Jan; 45(1):177-187. PubMed ID: 33049093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of the proton pump inhibitor lansoprazole on distribution and activity of doxorubicin in solid tumors.
    Yu M; Lee C; Wang M; Tannock IF
    Cancer Sci; 2015 Oct; 106(10):1438-47. PubMed ID: 26212113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton pump inhibitor selectively suppresses proliferation and restores the chemosensitivity of gastric cancer cells by inhibiting STAT3 signaling pathway.
    Huang S; Chen M; Ding X; Zhang X; Zou X
    Int Immunopharmacol; 2013 Nov; 17(3):585-92. PubMed ID: 23973653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pantoprazole increases cell viability and function of primary human osteoblasts in vitro.
    Prause M; Seeliger C; Unger M; van Griensven M; Haug AT
    Injury; 2014 Aug; 45(8):1156-64. PubMed ID: 24893920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erlotinib and pantoprazole: a relevant interaction or not?
    Ter Heine R; Fanggiday JC; Lankheet NA; Beijnen JH; Van Der Westerlaken MM; Staaks GH; Malingré MM
    Br J Clin Pharmacol; 2010 Dec; 70(6):908-11. PubMed ID: 21175447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autophagy inhibition with chloroquine reverts paclitaxel resistance and attenuates metastatic potential in human nonsmall lung adenocarcinoma A549 cells via ROS mediated modulation of β-catenin pathway.
    Datta S; Choudhury D; Das A; Mukherjee DD; Dasgupta M; Bandopadhyay S; Chakrabarti G
    Apoptosis; 2019 Jun; 24(5-6):414-433. PubMed ID: 30767087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of pantoprazole on human gastric adenocarcinoma SGC7901 cells through regulation of phospho‑LRP6 expression in Wnt/β-catenin signaling.
    Shen W; Zou X; Chen M; Shen Y; Huang S; Guo H; Zhang L; Liu P
    Oncol Rep; 2013 Aug; 30(2):851-5. PubMed ID: 23754096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton pump inhibitors can reverse the YAP mediated paclitaxel resistance in epithelial ovarian cancer.
    He J; Shi XY; Li ZM; Pan XH; Li ZL; Chen Y; Yan SJ; Xiao L
    BMC Mol Cell Biol; 2019 Nov; 20(1):49. PubMed ID: 31718559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunopotentiating effect of proton pump inhibitor pantoprazole in a lymphoma-bearing murine host: Implication in antitumor activation of tumor-associated macrophages.
    Vishvakarma NK; Singh SM
    Immunol Lett; 2010 Nov; 134(1):83-92. PubMed ID: 20837061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pantoprazole pretreatment elevates sensitivity to vincristine in drug-resistant oral epidermoid carcinoma in vitro and in vivo.
    Lu ZN; Shi ZY; Dang YF; Cheng YN; Guan YH; Hao ZJ; Tian B; He HW; Guo XL
    Biomed Pharmacother; 2019 Dec; 120():109478. PubMed ID: 31568987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pantoprazole blocks the JAK2/STAT3 pathway to alleviate skeletal muscle wasting in cancer cachexia by inhibiting inflammatory response.
    Guo D; Wang C; Wang Q; Qiao Z; Tang H
    Oncotarget; 2017 Jun; 8(24):39640-39648. PubMed ID: 28489606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.